F Oike
Overview
Explore the profile of F Oike including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ueda Y, Marusawa H, Kaido T, Ogura Y, Oike F, Mori A, et al.
J Viral Hepat
. 2010 Dec;
19(1):32-8.
PMID: 21129128
Approximately 30% of patients who have recurrent hepatitis C after liver transplantation achieve sustained virological response (SVR) by taking a combination therapy of pegylated interferon and ribavirin. For the remaining...
2.
Hori T, Ueda M, Oike F, Ogura Y, Ogawa K, Nguyen J, et al.
Transplant Proc
. 2010 Sep;
42(7):2642-4.
PMID: 20832560
Background: Arterioportal shunts (APS) are well-known critical complications after liver transplantation (OLT). The aims of this study were to assess the frequency and causes of APS after OLT and to...
3.
Hori T, Egawa H, Takada Y, Oike F, Kasahara M, Ogura Y, et al.
Am J Transplant
. 2010 Jul;
10(8):1951-2.
PMID: 20659101
No abstract available.
4.
Hori T, Oike F, Hata K, Nishikiori M, Ogura Y, Ogawa K, et al.
Transpl Infect Dis
. 2010 May;
12(4):347-52.
PMID: 20456713
A 55-year-old woman underwent living-donor liver transplantation (LDLT). She had no history of autoimmune diseases. Spleen was preserved. Steroids were withdrawn at 3 months after LDLT. Epstein-Barr virus (EBV) infection...
5.
Hori T, Ogura Y, Okamoto S, Nakajima A, Kami K, Iwasaki J, et al.
Transpl Infect Dis
. 2009 Dec;
12(4):353-7.
PMID: 20030795
Herpes simplex virus (HSV) hepatitis has a fatal impact on the outcome of organ transplanted recipients. Here, we present a thought-provoking case of HSV hepatitis in a high-risk recipient after...
6.
Fujiki M, Takada Y, Ogura Y, Oike F, Kaido T, Teramukai S, et al.
Am J Transplant
. 2009 Aug;
9(10):2362-71.
PMID: 19656125
Des-gamma-carboxy prothrombin (DCP) levels reportedly correlate with histological features of hepatocellular carcinoma (HCC). We examined serum DCP as a predictor of HCC recurrence in 144 patients who underwent living donor...
7.
Ueda M, Oike F, Kasahara M, Ogura Y, Ogawa K, Haga H, et al.
Am J Transplant
. 2008 Aug;
8(10):2097-105.
PMID: 18727696
The aim of this report is to assess the rate of portal vein complications (PVCs), the success rate of treatment for PVCs and the prognosis of patients with PVCs for...
8.
Masuda S, Goto M, Okuda M, Ogura Y, Oike F, Kiuchi T, et al.
Transplant Proc
. 2005 May;
37(4):1728-9.
PMID: 15919446
The role of intestinal P-glycoprotein (encoded by the MDR1/ABCB1 gene) and/or metabolic enzyme CYP3A4 for tacrolimus therapy was examined in recipients of living-donor liver transplantation (LDLT), under the hypothesis that...
9.
Yoshizawa A, Sakamoto S, Ogawa K, Kasahara M, Uryuhara K, Oike F, et al.
Transplant Proc
. 2005 May;
37(4):1718-9.
PMID: 15919443
Introduction: An ABO-incompatible (ABO-I) living donor liver transplantation (LDLT) is a challenge. Until 2000 systemic multidrug immunosuppression and splenectomy was the gold standard with poor results. Application of local administration...
10.
Kasahara M, Uryuhara K, Kaihara S, Kozaki K, Fujimoto Y, Ogura Y, et al.
Transplant Proc
. 2003 Jun;
35(4):1425-6.
PMID: 12826178
Background: Living donor liver transplant (LDLT) program has been started from 1990 in Japan, and is still major form of liver transplantation because of the scarcity of cadaveric donor organs....